Old Web
English
Sign In
Acemap
>
authorDetail
>
Graham D. Thomas
Graham D. Thomas
Pfizer
CD8
Biology
Cytotoxic T cell
T cell
Cancer research
5
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
2021
Journal for ImmunoTherapy of Cancer
Paola Marie Marcovecchio
Graham D. Thomas
Shahram Salek-Ardakani
Show All
Source
Cite
Save
Citations (2)
CD8+ T Cell Exhaustion in Cancer.
2021
Frontiers in Immunology
Joseph S. Dolina
Natalija Van Braeckel-Budimir
Graham D. Thomas
Shahram Salek-Ardakani
Show All
Source
Cite
Save
Citations (0)
Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
2021
Frontiers in Oncology
Graham D. Thomas
Luca Micci
Wenjing Yang
Joseph Katakowski
Cecilia Oderup
Purnima Sundar
Xiao Wang
Kenneth G. Geles
Shobha Potluri
Shahram Salek-Ardakani
Show All
Source
Cite
Save
Citations (0)
EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells
2021
Frontiers in Immunology
Christopher J. Stairiker
Sophia Pfister
Eleanore Hendrickson
Wenjing Yang
Tao Xie
Catherine Lee
Haikuo Zhang
Christopher P Dillon
Graham D. Thomas
Shahram Salek-Ardakani
Show All
Source
Cite
Save
Citations (0)
EZH2 as a Regulator of CD8+ T Cell Fate and Function
2020
Frontiers in Immunology
Christopher J. Stairiker
Graham D. Thomas
Shahram Salek-Ardakani
Show All
Source
Cite
Save
Citations (4)
1